Neurofibromin in the brain

Journal of Child Neurology

Volumn 17, Issue 8, 2002, Pages 592-601

  Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; NEUROFIBROMIN;

ASTROCYTE; ASTROCYTOMA; AUTOSOMAL DOMINANT DISORDER; BRAIN DISEASE; BRAIN NERVE CELL; BRAIN RADIOGRAPHY; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; COGNITIVE DEFECT; COMORBIDITY; DRUG TARGETING; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; LEARNING DISORDER; MOLECULAR GENETICS; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0036700880     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380201700809     Document Type: Review

References (63)

1. Gutmann DH, Aylsworth A, Carey JC, et al: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278:51-57.
2. Friedman JM, Gutmann DH, MacCollin M, Riccardi VM: Neurofibromatosis: Phenotype, Natural History and Pathogenesis. Baltimore, Johns Hopkins Press, 1999.
3. Huson SM, Harper PS, Compston DAS: Von Recklinghausen neurofibromatosis: A clinical and population study in south-east Wales. Brain 1988;111:1355-1381.
4. Viskochil D, Buchberg AM, Xu G, et al: Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990;62:187-192.
5. Cawthon RM, Weiss M, Xu G, et al: A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 1990;62:193-201.
6. Wallace MR, Marchuk DA, Andersen LB, et al: Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science 1990;249:181-186.
7. North K, Joy P, Yuille D, et al: Cognitive function and academic performance in children with neurofibromatosis type 1. Dev Med Child Neurol 1995;37:427-436.
8. Ozonoff S: Cognitive impairment in neurofibromatosis type 1. Am J Med Genet 1999;89:45-52.
9. North KK, Riccardi V, Samango-Sprouse C, et al: Cognitive function and academic performance in neurofibromatosis 1: Consensus statement from the NF1 Cognitive Disorders Task Force. Neurology 1997;48:1121-1127.
10. North K, Joy P, Yuille D, et al: Specific learning disability in children with neurofibromatosis type 1: Significance of MRI abnormalities. Neurology 1994;44:878-883.
11. Es SV, North KN, McHugh K, De Silva M: MRI findings in children with neurofibromatosis type 1: A prospective study. Pediatr Radiol 1996;26:478-487.
12. DiPaolo DP, Zimmerman RA, Rorke LB, et al: Neurofibromatosis type 1: Pathologic substrate of high signal intensity foci in the brain. Radiology 1995;195:721-724.
13. Moore BD, Slopis JM, Schomer D, et al: Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 1996;46:1660-1668.
14. Listernick R, Louis DN, Packer PJ, Gutmann DH: Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 1997;41:143-149.
15. Listernick R, Charrow J, Greenwald MJ, Esterly NB: Optic gliomas in children with neurofibromatosis type 1. J Pediatr 1989; 114:788-792.
16. Listernick R, Charrow J, Greenwald MJ, Mets M: Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study. J Pediatr 1994;125:63-66.
17. Habiby R, Silverman B, Listernick R, et al: Precocious puberty in children with neurofibromatosis type 1. J Pediatr 1995;126:364-367.
18. Molloy PT, Bilaniuk LT, Vaughan SN, et al: Brainstem gliomas in patients with neurofibromatosis type 1: A distinct clinical entity. Neurology 1995;45:1897-1902.
19. Pollack IF, Schultz B, Mulvihill JJ: The management of brainstem gliomas in patients with neurofibromatosis 1. Neurology 1996;46:1652-1660.
20. Daston MM, Scrable H, Norlund M, et al: The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells and oligodendrocytes. Neuron 1992;8:415-428.
21. Gutmann DH, Wood DL, Collins FS: Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci USA 1991;88:9658-9662.
22. DeClue JE, Cohen BD, Lowy DR: Identification and characterization of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci USA 1991;88:9914-9918.
23. Huynh DP, Lin CT, Pulst SM: Expression of neurofibromin, the neurofibromatosis type 1 gene product: Studies in human neuroblastoma cells and rat brain. Neurosci Lett 1992;143:233-236.
24. Xu G, O'Connell P, Viskochil D, et al: The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990;62:599-608.
25. Bollag G, McCormick F: Regulators and effectors of ras proteins. Annu Rev Cell Biol 1991;7:601-632.
26. Weinberg RA. Tumor suppressor genes. Neuron 1993;11:191-196.
27. Colman SD, Williams CA, Wallace MR: Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene. Nat Genet 1995;11:90-92.
28. Sawada S, Florell S, Purandare SM, et al: Identification of NF1 mutations in both alleles of a dermal neurofibroma. Nat Genet 1996; 14:110-112.
29. Brannan CI, Perkins AS, Vogel KS, et al: Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 1994;8:1019-1029.
30. Jacks T, Shih TS, Schmitt EM, et al: Tumor predisposition in mice heterozygous for a targeted mutation in NF1. Nat Genet 1994;7:353-361.
31. Li Y, White R: Suppression of a human colon cancer cell line by introduction of an exogenous NF1 gene. Cancer Res 1996;56:2872-2876.
32. Knudson AG Jr Mutation and cancer. Statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971;68:820-823.
33. Li C, Cheng Y, Gutmann DH, Mangoura D: Differential localization of the neurofibromatosis 1 (NF1) gene product, neurofibromin, with the F-actin or microtubule cytoskeleton during differentiation of telencephalic neurons. Dev Brain Res 2001;30:231-248.
34. Hewett SJ, Choi DW, Gutmann DH: Increased expression of the neurofibromatosis 1 (NF1) tumor suppressor gene protein, neurofibromin, in reactive astrocytes in vitro. Neuroreport 1995;6:1505-1508.
35. Gutmann DH, Loehr A, Zhang Y, et al: Haploinsufficiency for the neurofibromatosis 1 (NF1) tumor suppressor results in increased astrocyte proliferation. Oncogene 1999;18:4450-4459.
36. Giordano MJ, Mahadeo DK, He YY, et al: Increased expression of the neurofibromatosis 1 (NF1) gene product, neurofibromin, in astrocytes in response to cerebral ischemia. J Neurosci Res 1996;43:246-253.
37. Gutmann DH, Donahoe J, Brown T, et al: Loss of neurofibromatosis 1 (NF1) gene expression in NF1-associated pilocytic astrocytomas. Neuropathol Exp Neurobiol 2000;26:361-367.
38. Platten M, Giordano MJ, Dirvem CMF, et al: Upregulation of specific NF1 gene transcripts in sporadic pilocytic astrocytomas. Am J Pathol 1996;149:621-627.
39. Gutmann DH, Giordano MJ, Mahadeo DK, et al: Increased neurofibromatosis 1 gene expression in astrocytic tumors: Positive regulation by p2-ras. Oncogene 1996; 12:2121-2127.
40. Kluwe L, Hagel C, Tatagiba M, et al: Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas. J Neuropathol Exp Neurol 2001;60:917-920.
41. Li J, Perry A, James CD, Gutmann DH: Cancer-related gene expression in neurofibromatosis 1 (NF1)-associated pilocytic astrocytomas. Neurology 2001;56:885-890.
42. Gutmann DH, Hedrick NM, Li J, et al: Comparative gene expression profile analysis of neurofibromatosis 1 (NF1)-associated and sporadic pilocytic astrocytomes. Cancer Res 2002;62:2085-2091.
43. Figarella-Branger D, Daniel L, Andre P, et al: The PEN5 epitope identifies an oligodendrocyte precursor cell population and pilocytic astrocytomas. Am J Pathol 1999; 155:1261-1269.
44. Lau N, Feldkamp MM, Roncari L, et al: Loss of neurofibromin is associated with activation of ras/MAPK and PI3-K/akt signaling in a neurofibromatosis 1 astrocytoma. J Neuropathol Exp Neurol 2000;59:759-767.
45. Bajenaru ML, Donahoe J, Corral T, et al: Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes. Glia 2001;33:314-323.
46. Gutmann DH, Wu YL, Hedrick NM, et al: Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes. Hum Mol Genet 2001;10:3009-3016.
47. Bajenaru ML, Zhu Y, Hedrick NM, et al: Astrocyte-specific inactivation of the neurofibromatosis 1 (NF1) gene is insufficient for astrocytoma formation. Mol Cell Biol 2002;22:5100-5113.
48. Giovannini M, Robanus-Maandag E, Niwa-Kawakita M, et al: Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev 1999; 13:978-986.
49. Ding H, Roncari L, Shannon P, et al. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res 2001;61:3826-3836.
50. Huynh DP, Nechiporuk T, Pulst SM: Differential expression and tissue distribution of type I and type II neurofibromins during mouse fetal development. Dev Biol 1994;161:538-551.
51. Gutmann DH, Cole JL, Collins FS: Expression of the neurofibromatosis type 1 (NF1) gene during mouse embryonic development. Prog Brain Res 1995;105:327-335.
52. Gregory PE, Gutmann DH, Mitchell A, et al: Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. Somat Cell Mol Genet 1993;19:265-274.
53. Silva AJ, Frankland PW, Marowitz Z, et al: A mouse model for the learning and memory deficits associated with neurofibromatosis type 1. Nat Genet 1997;15:281-284.
54. Costa RM, Yang T, Huynh DP, et al: Learning deficits, but normal development and tumor predisposition, in mice lacking exon 23a of Nf1. Nat Genet 2001;27:399-405.
55. The I, Hannigan GE, Cowley GS, et al: Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science 1997;276:791-794.
56. Guo H-F, The I, Hannan F, et al: Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science 1997;276:795-798.
57. Williams JA, Su HS, Bernards A, et al: A circadian output in Drosophila mediated by neurofibromatosis-1 and Ras/MAPK. Science 2001;293:2251-2256.
58. Snider WD: Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell 1994;77:627-638.
59. Vogel KS, Brannan CI, Jenkins NA, et al: Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell 1995;82:733-742.
60. Vogel KS, Parada LF: Sympathetic neuron survival and proliferation are prolonged by loss of p53 and neurofibromin. Mol Cell Neurosci 1998;11:19-28.
61. Danglot G, Regnier V, Fauvet D, et al: Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5′ part of the gene. Hum Mol Genet 1995;4:915-920.
62. Geist RT, Gutmann DH: Expression of a developmentally-regulated neuron-specific isoform of the neurofibromatosis 1 (NF1) gene. Neurosci Lett 1996;211:85-88.
63. Gutmann DH, Zhang Y, Hirbe A: Developmental regulation of a neuron-specific neurofibromatosis 1 isoform. Ann Neurol 1999;45:777-782.